Interesting drug

The human cost of depression is often communicated in very big numbers: the vast economic losses and the legions of sufferers worldwide. It is, nevertheless, an illness of individuals. Mark has suffered from depression all of his adult life. “If this is living then this sucks”, he says. John is devoted to his family but has been unable to play a full part in their lives for close to a decade. The strain this puts on his wife is considerable. Andy has been depressed since a change in the circumstances of his job 13 year ago. All three men have tried numerous treatments with only transient benefit. They are among 12 people recruited to take part in a trial to take psilocybin, the psychoactive compound in hallucinogenic mushrooms. Will this help where other approaches have failed?